We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$314M
AUM Growth
+$10.3M
Cap. Flow
-$980K
Cap. Flow %
-0.31%
Top 10 Hldgs %
73.99%
Holding
80
New
20
Increased
31
Reduced
6
Closed
14

Sector Composition

1 Financials 13.61%
2 Healthcare 12.49%
3 Communication Services 6.16%
4 Technology 3.98%
5 Materials 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$138M 44.05%
550,000
+70,000
+15% +$17.3M
GS icon
2
Goldman Sachs
GS
$314B
$19.5M 6.21%
82,176
-511
-0.6% -$115K
HCA icon
3
HCA Healthcare
HCA
$82.3B
$12.8M 4.07%
160,490
+4
+0% +$322
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.22T
$11.9M 3.79%
248,100
+2,480
+1% +$116K
JPM icon
5
JPMorgan Chase
JPM
$907B
$11.2M 3.58%
117,565
-94
-0.1% -$8.67K
NEOS
6
DELISTED
Neos Therapeutics, Inc
NEOS
$9.55M 3.04%
1,043,770
APTV icon
7
Aptiv
APTV
$12.2B
$7.38M 2.35%
75,000
APTV icon
8
PUT
Aptiv
APTV
$12.2B
$7.38M 2.35%
+75,000
New +$7.08M
BERY
9
DELISTED
Berry Global Group, Inc.
BERY
$7.37M 2.35%
141,570
ATH
10
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$6.86M 2.19%
127,419
ZVRA icon
11
Zevra Therapeutics
ZVRA
$755M
$6.63M 2.11%
111,977
+20,777
+23% +$1.11M
FOMX
12
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$6.59M 2.1%
1,187,604
+950
+0.1% +$4.91K
GS icon
13
PUT
Goldman Sachs
GS
$314B
$5.93M 1.89%
25,000
-55,000
-69% -$12.4M
TEL icon
14
TE Connectivity
TEL
$59.3B
$5.23M 1.67%
63,000
PARA
15
DELISTED
Paramount Global Class B
PARA
$4.93M 1.57%
85,000
XBI icon
16
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$4.33M 1.38%
50,000
TLT icon
17
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$3.93M 1.25%
+31,500
New +$3.96M
QQQ icon
18
PUT
Invesco QQQ Trust
QQQ
$466B
$3.64M 1.16%
+25,000
New +$3.58M
NSTG
19
DELISTED
NanoString Technologies, Inc.
NSTG
$2.67M 0.85%
165,000
-161,006
-49% -$2.48M
GLD icon
20
SPDR Gold Trust
GLD
$130B
$2.66M 0.85%
+21,860
New +$2.66M
DFS
21
DELISTED
Discover Financial Services
DFS
$2.45M 0.78%
+38,000
New +$2.3M
HCA icon
22
CALL
HCA Healthcare
HCA
$82.3B
$2.39M 0.76%
+30,000
New +$2.41M
PARA
23
CALL
DELISTED
Paramount Global Class B
PARA
$2.03M 0.65%
+35,000
New +$2.21M
IWN icon
24
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.98M 0.63%
15,960
+5,520
+53% +$651K
MSFT icon
25
Microsoft
MSFT
$2.93T
$1.34M 0.43%
17,995
+5,499
+44% +$402K

Similar funds

DSC Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, DSC Advisors held 80 positions worth $314M, up 3.4% from $303M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DSC Advisors's Q3 2017 filing shows 20 new, 31 increased, 6 reduced and 14 closed positions. Its largest new stake was SPDR Gold Trust: 21,860 shares worth $2.66M. The largest sale was CVS Health, an estimated $6.5M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • DSC Advisors's largest Q3 2017 buy was SPDR Gold Trust: 21,860 shares worth $2.66M.
  • DSC Advisors added most to Zevra Therapeutics in Q3 2017, an estimated $1.11M increase.
  • DSC Advisors's biggest Q3 2017 reduction was NanoString Technologies, Inc., cutting an estimated $2.48M.
  • DSC Advisors fully exited CVS Health in Q3 2017, selling an estimated $6.5M.
  • DSC Advisors's ten largest holdings make up 74% of its $314M portfolio in Q3 2017.
  • DSC Advisors opened 20 new positions and closed 14 in Q3 2017.
  • DSC Advisors's portfolio value rose 3.4% quarter-over-quarter to $314M.

Based on DSC Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.